-The Times of India The present food Bill legalises the injustices of a targeted distribution system A national campaign throughout the month of July on issues related to food security and against rising prices will culminate in a five-day sit-in protest in Delhi beginning today. These are issues fundamental to the well-being of the majority of our people and therefore deserve national support. With the spectre of drought haunting the countryside, speculators, hoarders...
More »SEARCH RESULT
Total Matching Records found : 854
Madhav Gadgil, ex member of NAC interviewed by Sreelatha Menon
-The Business Standard Madhav Gadgil headed the Western Ghats Ecology Expert Panel set up by the ministry of environment and forests in 2010. The report zoned 75 per cent of the Western Ghats into different grades of ecological sensitivity. The recommendation was to protect these zones with measures by phasing out mining and introducing organic farming and eco-friendly urbanisation. The report also proposed a development model executed in consultation with the...
More »Hunger kills 1 every week in Delhi
-The Times of India For a government that flaunts the “global city” tag, here is some disturbing news. A recent RTI reply from four Delhi Police districts – out of a total of 11 – received by RTI activist Nayaar Alam has revealed that the city witnessed 737 deaths in the past 14 years either due to hunger or poverty. All deaths were due to hunger or suicides due to hunger...
More »The perils of retail therapy in India
-Live Mint There is no dearth of advisors for a government considered to be in the grip of a policy paralysis and whose prime minister is dubbed an “underachiever”. In this season of India-bashing, US President Barack Obama spared some time from his election campaign and offered some pearly words of wisdom on the Indian economy. This came at a time when in his own backyard, thousands of people marched in...
More »Natco targets drugs ripe for compulsory licensing-Viswanath Pilla
-Live Mint Natco Pharma Ltd, which has started selling a generic version of Bayer AG’s patented cancer treatment Nexavar in India at a fraction of the price charged by the German firm, plans to use the so-called compulsory licensing route to try and win the right to copy more patented drugs, said vice-chairman and chief executive officer Rajeev Nannapaneni. The Hyderabad-based company has already identified the patented drugs for which it will...
More »
